. . . . . . . . . "The on‐label indication for Brintellix is depression; we identified the following off‐label indications: schizophrenia, episodic mood disorders, anxiety disorders, personality disorders, bipolar depression, post‐traumatic stress disorder, and chronic pain." . . . . . . "Adults" . . "2021-08-17T12:40:57.221489"^^ . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB" . "PxOBuLUl3KPyH+3i6milxDlERaeSIZINQFPNo/pRUU95H9v5v2exKOG+IW5jrVu22BA/PSJjba6444TF0+brfV+aONMMFSAo+eq5S7qu2zQFTzpPThb5oIw3nrCsPeIQxcAq2XhR/x40fmySEDSwxtPghpPS/rzCBhImC8M/S0o=" . . "2021-08-17T12:40:57.221489"^^ . . .